Drug Repositioning Industry Research Report 2023
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Highlights
The global Drug Repositioning market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Repositioning, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repositioning.
The Drug Repositioning market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Repositioning market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Repositioning companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Drug Repositioning type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Drug Repositioning are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Drug Repositioning segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Drug Repositioning market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drug Repositioning market.
Drug Repositioning Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug Repositioning market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Repositioning market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drug Repositioning and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug Repositioning industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Repositioning.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Repositioning companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global Drug Repositioning market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
Global Drug Repositioning key players include Teva, Novartis, Mylan, Johnson & Johnson, Pfizer, etc. Global top five manufacturers hold a share about 15%.
North America is the largest market, with a share about 40%, followed by Europe and China, both have a share over 30 percent.
In terms of product, Generic Drugs is the largest segment, with a share about 65%. And in terms of application, the largest application is Cancer, followed by Cardiovascular Diseases.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Repositioning, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Repositioning.
The Drug Repositioning market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Drug Repositioning market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Repositioning companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Teva
- Novartis
- Mylan
- Johnson & Johnson
- Pfizer
- Bausch Health
- GSK
- ChemRar Group
- Glenmark
- Fujifilm
- Dr. Reddy
- R-Pharma
Global markets are presented by Drug Repositioning type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Drug Repositioning are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Drug Repositioning segment by Type
- Generic Drugs
- Clinical Trial Failed Drugs
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Drug Repositioning market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drug Repositioning market.
Drug Repositioning Segment by Application
- Cardiovascular Diseases
- Mental Illness
- Cancer
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug Repositioning market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Repositioning market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drug Repositioning and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug Repositioning industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Repositioning.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Repositioning companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
- What factors will challenge the Product Name market growth?
- Which end-use segment will expand at the fastest CAGR in the Product Name market?
- Which are the emerging players in the Product Name market?
- How concentrated is the Product Name market?
- Which factors are positively contributing to the Product Name market growth?
- Which are the novel product innovations in the Product Name market?
- Which product segment will emerge as the most lucrative in the Product Name market?
- Which factors are increasing the competition in the Product Name market?
- Which are the strategic measures taken by the Product Name industry players?
- Which region will witness inactive growth during the forecast period?
- What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drug Repositioning Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Drug Repositioning Revenue Market Share by Type (2018-2023)
Table 7. Global Drug Repositioning Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Drug Repositioning Revenue Market Share by Type (2024-2029)
Table 9. Global Drug Repositioning Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Drug Repositioning Revenue Market Share by Application (2018-2023)
Table 11. Global Drug Repositioning Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Drug Repositioning Revenue Market Share by Application (2024-2029)
Table 13. Global Drug Repositioning Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Drug Repositioning Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Drug Repositioning Market Share by Region (2018-2023)
Table 16. Global Drug Repositioning Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Drug Repositioning Market Share by Region (2024-2029)
Table 18. Drug Repositioning Market Trends
Table 19. Drug Repositioning Market Drivers
Table 20. Drug Repositioning Market Challenges
Table 21. Drug Repositioning Market Restraints
Table 22. Global Top Drug Repositioning Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Drug Repositioning Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Drug Repositioning Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Drug Repositioning, Headquarters and Area Served
Table 26. Global Drug Repositioning Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Drug Repositioning by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 45. Teva Company Detail
Table 46. Teva Business Overview
Table 47. Teva Drug Repositioning Product
Table 48. Teva Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 49. Teva Recent Development
Table 50. Novartis Company Detail
Table 51. Novartis Business Overview
Table 52. Novartis Drug Repositioning Product
Table 53. Novartis Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Mylan Company Detail
Table 56. Mylan Business Overview
Table 57. Mylan Drug Repositioning Product
Table 58. Mylan Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 59. Mylan Recent Development
Table 60. Johnson & Johnson Company Detail
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Drug Repositioning Product
Table 63. Johnson & Johnson Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Pfizer Company Detail
Table 66. Pfizer Business Overview
Table 67. Pfizer Drug Repositioning Product
Table 68. Pfizer Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Bausch Health Company Detail
Table 71. Bausch Health Business Overview
Table 72. Bausch Health Drug Repositioning Product
Table 73. Bausch Health Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 74. Bausch Health Recent Development
Table 75. GSK Company Detail
Table 76. GSK Business Overview
Table 77. GSK Drug Repositioning Product
Table 78. GSK Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 79. GSK Recent Development
Table 80. ChemRar Group Company Detail
Table 81. ChemRar Group Business Overview
Table 82. ChemRar Group Drug Repositioning Product
Table 83. ChemRar Group Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 84. ChemRar Group Recent Development
Table 85. Glenmark Company Detail
Table 86. Glenmark Business Overview
Table 87. Glenmark Drug Repositioning Product
Table 88. Glenmark Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 89. Glenmark Recent Development
Table 90. Fujifilm Company Detail
Table 91. Fujifilm Business Overview
Table 92. Fujifilm Drug Repositioning Product
Table 93. Fujifilm Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 94. Fujifilm Recent Development
Table 95. Dr. Reddy Company Detail
Table 96. Dr. Reddy Business Overview
Table 97. Dr. Reddy Drug RepositioningProduct
Table 98. Dr. Reddy Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 99. Dr. Reddy Recent Development
Table 100. R-Pharma Company Detail
Table 101. R-Pharma Business Overview
Table 102. R-Pharma Drug RepositioningProduct
Table 103. R-Pharma Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 104. R-Pharma Recent Development
Table 105. Teva Company Information
Table 106. Teva Business Overview
Table 107. Teva Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 108. Teva Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 109. Teva Recent Development
Table 110. Novartis Company Information
Table 111. Novartis Business Overview
Table 112. Novartis Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 113. Novartis Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 114. Novartis Recent Development
Table 115. Mylan Company Information
Table 116. Mylan Business Overview
Table 117. Mylan Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 118. Mylan Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 119. Mylan Recent Development
Table 120. Johnson & Johnson Company Information
Table 121. Johnson & Johnson Business Overview
Table 122. Johnson & Johnson Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 123. Johnson & Johnson Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 124. Johnson & Johnson Recent Development
Table 125. Pfizer Company Information
Table 126. Pfizer Business Overview
Table 127. Pfizer Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 128. Pfizer Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 129. Pfizer Recent Development
Table 130. Bausch Health Company Information
Table 131. Bausch Health Business Overview
Table 132. Bausch Health Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 133. Bausch Health Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 134. Bausch Health Recent Development
Table 135. GSK Company Information
Table 136. GSK Business Overview
Table 137. GSK Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 138. GSK Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 139. GSK Recent Development
Table 140. ChemRar Group Company Information
Table 141. ChemRar Group Business Overview
Table 142. ChemRar Group Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 143. ChemRar Group Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 144. ChemRar Group Recent Development
Table 145. Glenmark Company Information
Table 146. Glenmark Business Overview
Table 147. Glenmark Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 148. Glenmark Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 149. Glenmark Recent Development
Table 150. Fujifilm Company Information
Table 151. Fujifilm Business Overview
Table 152. Fujifilm Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 153. Fujifilm Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 154. Fujifilm Recent Development
Table 155. Dr. Reddy Company Information
Table 156. Dr. Reddy Business Overview
Table 157. Dr. Reddy Drug RepositioningRevenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 158. Dr. Reddy Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 159. Dr. Reddy Recent Development
Table 160. R-Pharma Company Information
Table 161. R-Pharma Business Overview
Table 162. R-Pharma Drug RepositioningRevenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 163. R-Pharma Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 164. R-Pharma Recent Development
Table 165. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Drug Repositioning Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Drug Repositioning Revenue Market Share by Type (2018-2023)
Table 7. Global Drug Repositioning Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Drug Repositioning Revenue Market Share by Type (2024-2029)
Table 9. Global Drug Repositioning Market Size by Application (2018-2023) & (US$ Million)
Table 10. Global Drug Repositioning Revenue Market Share by Application (2018-2023)
Table 11. Global Drug Repositioning Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 12. Global Drug Repositioning Revenue Market Share by Application (2024-2029)
Table 13. Global Drug Repositioning Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Drug Repositioning Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Drug Repositioning Market Share by Region (2018-2023)
Table 16. Global Drug Repositioning Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Drug Repositioning Market Share by Region (2024-2029)
Table 18. Drug Repositioning Market Trends
Table 19. Drug Repositioning Market Drivers
Table 20. Drug Repositioning Market Challenges
Table 21. Drug Repositioning Market Restraints
Table 22. Global Top Drug Repositioning Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Drug Repositioning Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Drug Repositioning Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Drug Repositioning, Headquarters and Area Served
Table 26. Global Drug Repositioning Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Drug Repositioning by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Drug Repositioning Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Drug Repositioning Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Drug Repositioning Market Size by Country (2024-2029) & (US$ Million)
Table 45. Teva Company Detail
Table 46. Teva Business Overview
Table 47. Teva Drug Repositioning Product
Table 48. Teva Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 49. Teva Recent Development
Table 50. Novartis Company Detail
Table 51. Novartis Business Overview
Table 52. Novartis Drug Repositioning Product
Table 53. Novartis Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Mylan Company Detail
Table 56. Mylan Business Overview
Table 57. Mylan Drug Repositioning Product
Table 58. Mylan Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 59. Mylan Recent Development
Table 60. Johnson & Johnson Company Detail
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Drug Repositioning Product
Table 63. Johnson & Johnson Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Pfizer Company Detail
Table 66. Pfizer Business Overview
Table 67. Pfizer Drug Repositioning Product
Table 68. Pfizer Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 69. Pfizer Recent Development
Table 70. Bausch Health Company Detail
Table 71. Bausch Health Business Overview
Table 72. Bausch Health Drug Repositioning Product
Table 73. Bausch Health Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 74. Bausch Health Recent Development
Table 75. GSK Company Detail
Table 76. GSK Business Overview
Table 77. GSK Drug Repositioning Product
Table 78. GSK Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 79. GSK Recent Development
Table 80. ChemRar Group Company Detail
Table 81. ChemRar Group Business Overview
Table 82. ChemRar Group Drug Repositioning Product
Table 83. ChemRar Group Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 84. ChemRar Group Recent Development
Table 85. Glenmark Company Detail
Table 86. Glenmark Business Overview
Table 87. Glenmark Drug Repositioning Product
Table 88. Glenmark Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 89. Glenmark Recent Development
Table 90. Fujifilm Company Detail
Table 91. Fujifilm Business Overview
Table 92. Fujifilm Drug Repositioning Product
Table 93. Fujifilm Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 94. Fujifilm Recent Development
Table 95. Dr. Reddy Company Detail
Table 96. Dr. Reddy Business Overview
Table 97. Dr. Reddy Drug RepositioningProduct
Table 98. Dr. Reddy Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 99. Dr. Reddy Recent Development
Table 100. R-Pharma Company Detail
Table 101. R-Pharma Business Overview
Table 102. R-Pharma Drug RepositioningProduct
Table 103. R-Pharma Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
Table 104. R-Pharma Recent Development
Table 105. Teva Company Information
Table 106. Teva Business Overview
Table 107. Teva Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 108. Teva Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 109. Teva Recent Development
Table 110. Novartis Company Information
Table 111. Novartis Business Overview
Table 112. Novartis Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 113. Novartis Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 114. Novartis Recent Development
Table 115. Mylan Company Information
Table 116. Mylan Business Overview
Table 117. Mylan Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 118. Mylan Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 119. Mylan Recent Development
Table 120. Johnson & Johnson Company Information
Table 121. Johnson & Johnson Business Overview
Table 122. Johnson & Johnson Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 123. Johnson & Johnson Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 124. Johnson & Johnson Recent Development
Table 125. Pfizer Company Information
Table 126. Pfizer Business Overview
Table 127. Pfizer Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 128. Pfizer Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 129. Pfizer Recent Development
Table 130. Bausch Health Company Information
Table 131. Bausch Health Business Overview
Table 132. Bausch Health Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 133. Bausch Health Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 134. Bausch Health Recent Development
Table 135. GSK Company Information
Table 136. GSK Business Overview
Table 137. GSK Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 138. GSK Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 139. GSK Recent Development
Table 140. ChemRar Group Company Information
Table 141. ChemRar Group Business Overview
Table 142. ChemRar Group Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 143. ChemRar Group Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 144. ChemRar Group Recent Development
Table 145. Glenmark Company Information
Table 146. Glenmark Business Overview
Table 147. Glenmark Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 148. Glenmark Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 149. Glenmark Recent Development
Table 150. Fujifilm Company Information
Table 151. Fujifilm Business Overview
Table 152. Fujifilm Drug Repositioning Revenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 153. Fujifilm Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 154. Fujifilm Recent Development
Table 155. Dr. Reddy Company Information
Table 156. Dr. Reddy Business Overview
Table 157. Dr. Reddy Drug RepositioningRevenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 158. Dr. Reddy Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 159. Dr. Reddy Recent Development
Table 160. R-Pharma Company Information
Table 161. R-Pharma Business Overview
Table 162. R-Pharma Drug RepositioningRevenue in Drug Repositioning Business (2018-2023) & (US$ Million)
Table 163. R-Pharma Revenue in Drug Repositioning Business (2018-2023) & (US$ Million) Portfolio
Table 164. R-Pharma Recent Development
Table 165. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug Repositioning Product Picture
Figure 5. Global Drug Repositioning Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Drug Repositioning Market Share by Type: 2022 VS 2029
Figure 7. Generic Drugs Product Picture
Figure 8. Clinical Trial Failed Drugs Product Picture
Figure 9. Global Drug Repositioning Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Drug Repositioning Market Share by Application: 2022 VS 2029
Figure 11. Cardiovascular Diseases Product Picture
Figure 12. Mental Illness Product Picture
Figure 13. Cancer Product Picture
Figure 14. Others Product Picture
Figure 15. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Drug Repositioning Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Drug Repositioning Market Share by Region: 2022 VS 2029
Figure 18. Global Drug Repositioning Market Share by Players in 2022
Figure 19. Global Drug Repositioning Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Drug Repositioning Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Drug Repositioning Market Share by Country (2018-2029)
Figure 24. United States Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Drug Repositioning Market Share by Country (2018-2029)
Figure 28. Germany Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Drug Repositioning Market Share by Country (2018-2029)
Figure 36. China Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Drug Repositioning Market Share by Country (2018-2029)
Figure 44. Mexico Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Drug Repositioning Market Share by Country (2018-2029)
Figure 48. Turkey Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Teva Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 53. Mylan Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 54. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 55. Pfizer Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 56. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 57. GSK Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 58. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 59. Glenmark Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 60. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 61. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 62. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Drug Repositioning Product Picture
Figure 5. Global Drug Repositioning Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Drug Repositioning Market Share by Type: 2022 VS 2029
Figure 7. Generic Drugs Product Picture
Figure 8. Clinical Trial Failed Drugs Product Picture
Figure 9. Global Drug Repositioning Market Size by Application (2023-2029) & (US$ Million)
Figure 10. Global Drug Repositioning Market Share by Application: 2022 VS 2029
Figure 11. Cardiovascular Diseases Product Picture
Figure 12. Mental Illness Product Picture
Figure 13. Cancer Product Picture
Figure 14. Others Product Picture
Figure 15. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Drug Repositioning Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Drug Repositioning Market Share by Region: 2022 VS 2029
Figure 18. Global Drug Repositioning Market Share by Players in 2022
Figure 19. Global Drug Repositioning Players, Date of Enter into This Industry
Figure 20. Global Top 5 and 10 Drug Repositioning Players Market Share by Revenue in 2022
Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 22. North America Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Drug Repositioning Market Share by Country (2018-2029)
Figure 24. United States Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Drug Repositioning Market Share by Country (2018-2029)
Figure 28. Germany Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Drug Repositioning Market Share by Country (2018-2029)
Figure 36. China Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Japan Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. South Korea Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Southeast Asia Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. India Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Australia Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Drug Repositioning Market Share by Country (2018-2029)
Figure 44. Mexico Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Brazil Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Drug Repositioning Market Share by Country (2018-2029)
Figure 48. Turkey Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Saudi Arabia Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. UAE Drug Repositioning Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Teva Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 53. Mylan Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 54. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 55. Pfizer Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 56. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 57. GSK Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 58. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 59. Glenmark Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 60. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 61. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2018-2023)
Figure 62. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2018-2023)
